Senna Laxative Recall: Label Mix-Up with Naproxen Sodium
Magno Humphries recalls Senna Laxative bottles due to a label mix-up. Bottles labeled as Senna may contain Naproxen Sodium tablets.
Stop using this now
Labeling: Label Mix-Up: Customer complaint received that a bottle labeled as Senna Laxative contained only tablets of Naproxen Sodium 220 mg.
Contact the company
What happened, in plain English
Magno Humphries Laboratories, Inc. is recalling Senna Laxative (sennosides) tablets because of a labeling error. Some bottles labeled as containing the laxative actually contain Naproxen Sodium 220 mg tablets instead. This mix-up poses a risk to consumers who may take the wrong medication. Read more at govinfonow.com/recall/40928-senna-laxative-recall-label-mix-up-with-naproxen-sodium.
Source Summary by GovInfoNow · govinfonow.com/recall/40928-senna-laxative-recall-label-mix-up-with-naproxen-sodium · Updated October 11, 2026 · FDA enforcement record: FDA #D-0342-2018
Cite this page
“Senna Laxative Recall: Label Mix-Up with Naproxen Sodium.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/40928-senna-laxative-recall-label-mix-up-with-naproxen-sodium. Based on FDA recall #D-0342-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0342-2018%22&limit=1).
Why it’s dangerous
The hazard is a labeling error where bottles intended to contain Senna Laxative were filled with Naproxen Sodium tablets. Taking Naproxen Sodium when expecting a laxative can lead to unintended drug exposure, potential allergic reactions, or ineffective treatment of constipation.
Who’s affected
Consumers who purchased 100-count bottles of Senna Laxative manufactured by Magno Humphries Laboratories and sold nationwide in the USA are affected. Individuals relying on this product for laxative purposes or those who cannot take Naproxen Sodium are at particular risk.
How to tell if you have this one
Check your bottle for the UPC Code 3 07610 22020 1 and Lot # 352300. The expiration date on the bottle is Exp 01/19. The label should say Senna Laxative (sennosides) tablets, 8.6 mg, but may contain Naproxen Sodium 220 mg tablets.
- Brand
Magno Humphries Laboratories- Product
Senna Laxative (sennosides) tablets, 8.6 mg, 100-count bottles, Manufactured for: Basic Drugs, Inc., Vandalia, Ohio- Category
Drug
What to do — step by step
Stop using the product
Do not consume the tablets in bottles matching the recalled lot and UPC code.
Check your bottle details
Verify if your bottle has UPC Code 3 07610 22020 1 and Lot # 352300 with an expiration date of Exp 01/19.
Contact the manufacturer
Reach out to Magno Humphries Laboratories, Inc. for further instructions on returning or disposing of the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 23 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0342-2018 (January 17, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0342-2018 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.